menu
    • menu

    Company profile for Clovis Oncology

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Clovis’ product development programs generally target specific subsets of cancer, and the Company seeks to simultaneously develop, with partners, diagnostic tools intended to direct a compound in develop...
    Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Clovis’ product development programs generally target specific subsets of cancer, and the Company seeks to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clovis OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5500 Flatiron Parkway Suite 100 Boulder, CO 80301
    Telephone
    Telephone
    303-625-5000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://clovisoncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clovis-oncology/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/clovisoncology

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA sends CRL to Clovis in last-gasp bid for Rubraca nod
    FDA sends CRL to Clovis in last-gasp bid for Rubraca nod

    06 Jun 2023

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fda-rejects-clovis-long-shot-bid-approval-rubraca

    Kevin Dunleavy FIERCE PHARMA
    06 Jun 2023
    Share Share
    With Clovis in Chapter 11, Swiss firm buys up Rubraca for $70M
    With Clovis in Chapter 11, Swiss firm buys up Rubraca for $70M

    08 Apr 2023

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/pharma/bankruptcy-clovis-sells-remaining-assets-including-rubraca-70m

    Kevin Dunleavy FIERCE PHARMA
    08 Apr 2023
    Share Share
    Clovis reveals even more regulatory troubles for Rubraca
    Clovis reveals even more regulatory troubles for Rubraca

    13 Feb 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/ema-requests-more-data-fda-spots-potential-harm-clovis-limps-through-rubraca-apps-amid

    Angus Liu FIERCE PHARMA
    13 Feb 2023
    Share Share
    Embattled Clovis Oncology Files for bankruptcy, Sells pipeline asset to Novartis
    Embattled Clovis Oncology Files for bankruptcy, Sells pipeline asset to Novartis

    13 Dec 2022

    // Alex Keown BIOSPACE

    https://www.biospace.com/article/embattled-clovis-oncology-files-for-chapter-11-sells-radioligand-therapeutic-to-novartis/

    Alex Keown BIOSPACE
    13 Dec 2022
    Share Share
    Cancer drugmaker Clovis files for bankruptcy, hit by falling sales
    Cancer drugmaker Clovis files for bankruptcy, hit by falling sales

    12 Dec 2022

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-drugmaker-clovis-files-chapter-11-bankruptcy-2022-12-12/

    REUTERS
    12 Dec 2022
    Share Share
    Clovis Oncology Enters into Agreement to Sell FAP-2286
    Clovis Oncology Enters into Agreement to Sell FAP-2286

    12 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221211005087/en

    BUSINESSWIRE
    12 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search